WOCKHARDT
Back to Balance Sheet
|
WOCKHARDT Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-514 Cr | ₹-544 Cr | ₹-576 Cr | ₹-545 Cr | ₹-370 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of WOCKHARDT ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-514 Cr |
| Mar2024 | ₹-544 Cr |
| Mar2023 | ₹-576 Cr |
| Mar2022 | ₹-545 Cr |
| Mar2021 | ₹-370 Cr |
How is Deferred Tax Assets / Liabilities of WOCKHARDT Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-514 Cr | Negative | |
| Mar2024 | ₹-544 Cr | Negative | |
| Mar2023 | ₹-576 Cr | Negative | |
| Mar2022 | ₹-545 Cr | Negative | |
| Mar2021 | ₹-370 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹31,672.1 Cr | -3.2% | 10% | 13.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,299.0 Cr | 0.5% | 1.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹174,207.0 Cr | -3.3% | -3.5% | 1.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹157,721.0 Cr | 4.5% | 2.6% | 42.6% | Stock Analytics | |
| CIPLA | ₹117,420.0 Cr | 2.7% | 2.5% | -4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,876.0 Cr | 6.6% | 4.3% | 1.9% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -3.2% |
10% |
13.5% |
| SENSEX | -0.1% |
1% |
-5.7% |
You may also like the below Video Courses